CDKN2B and adenoma: Promoter hypermethylation of CDKN2A/p16 and CDKN2B/p15 is considerably more common in parathyroid carcinomas than in benign adenomas, and it shows a positive correlation with increased cell proliferation as indicated by Ki-67 overexpression (66).